2VYA | B:34-574; A:33-575 | CRYSTAL STRUCTURE OF FATTY ACID AMIDE HYDROLASE CONJUGATED WITH THE DRUG-LIKE INHIBITOR PF-750 |
2WAP | A:33-573; B:31-573 | 3D-CRYSTAL STRUCTURE OF HUMANIZED-RAT FATTY ACID AMIDE HYDROLASE (FAAH) CONJUGATED WITH THE DRUG-LIKE UREA INHIBITOR PF-3845 |
2WJ1 | A:34-576; B:34-577 | 3D-CRYSTAL STRUCTURE OF HUMANIZED-RAT FATTY ACID AMIDE HYDROLASE (FAAH) CONJUGATED WITH 7-PHENYL-1-(4-(PYRIDIN-2-YL)OXAZOL-2-YL)HEPTAN-1-ONE, AN ALPHA-KETOOXAZOLE |
2WJ2 | B:33-577; A:33-578 | 3D-CRYSTAL STRUCTURE OF HUMANIZED-RAT FATTY ACID AMIDE HYDROLASE (FAAH) CONJUGATED WITH 7-PHENYL-1-(5-(PYRIDIN-2-YL)OXAZOL-2-YL)HEPTAN-1-ONE, AN ALPHA-KETOOXAZOLE |
3K7F | A:32-574; B:33-577 | CRYSTAL STRUCTURE ANALYSIS OF A PHENHEXYL/OXAZOLE/CARBOXYPYRIDINE ALPHA-KETOHETEROCYCLE INHIBITOR BOUND TO A HUMANIZED VARIANT OF FATTY ACID AMIDE HYDROLASE' |
3K83 | B:33-577; A:33-578 | CRYSTAL STRUCTURE ANALYSIS OF A BIPHENYL/OXAZOLE/CARBOXYPYRIDINE ALPHA-KETOHETEROCYCLE INHIBITOR BOUND TO A HUMANIZED VARIANT OF FATTY ACID AMIDE HYDROLASE |
3K84 | B:32-574; A:33-578 | CRYSTAL STRUCTURE ANALYSIS OF A OLEYL/OXADIAZOLE/PYRIDINE INHIBITOR BOUND TO A HUMANIZED VARIANT OF FATTY ACID AMIDE HYDROLASE |